Research & Development

Navigating the maelstrom of M&A activity: what do CDMOs do next?

In an increasingly competitive market for contract service providers, do outsourcing companies acquire, grow or take a strategically vertical or horizontal approach to service integration to live, thrive and survive? Dr Kevin Robinson recently caught up with experts from Cognizant, Samsung Biologics and Vibalogics to pose this question and find out more

Breaking News

NorthX Biologics expands cell therapy partnership with Alder Therapeutics

Sweden-based NorthX Biologics is expanding into cell therapy manufacturing at its existing GMP facility as well as in premises at the Karolinska Un...

Streamlined production of nanoparticles for optimised drug delivery

Phosphorex, a contract development and manufacturing organisation specialising in the production of particle-based formulations – is using the Auto...

Medix Biochemica broadens its capabilities in diagnostic base matrices with acquisition

The acquisition is another important step in the execution of Medix Biochemica’s strategy to be the first-choice raw material partner to the IVD in...

Manufacturing Chemist LIVE 2022 in review (part II)

Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and excit...

Aptamer Group signs deal with Flip Gene Therapeutics to support the development of inducible gene therapies

Optimer binders will be developed as a gene switch to enable control of gene therapy expression

Banook Group continues global expansion with US office opening

New Boston office strengthens position in US market, providing local support and greater responsiveness for clinical trials

Overcoming bioanalytical hurdles in the pharma and life sciences sector

A new era of innovation and advancement in drug design, and modalities such as cell and gene therapies (CGTs), have led to the development of promi...

Manufacturing Chemist LIVE 2022 in review (part I)

Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and excit...

Coave and ABL enter gene therapy manufacturing process collab

The two French companies have joined forces to co-develop manufacturing technologies for AAV-based gene therapy products

Merck announces collaboration with Agilent to fill PAT gap for downstream processing

Collaboration will help to enable real-time release and Bioprocessing 4.0

Navigating the maelstrom of M&A activity: what do CDMOs do next?

In an increasingly competitive market for contract service providers, do outsourcing companies acquire, grow or take a strategically vertical or ho...

Native mass spectrometry as a drug discovery engine

Using mass spectrometry to characterise and screen large intact protein targets, captured directly in their native state, is making waves as a diff...

Bachem signs 7-year agreement with Eli Lilly to accelerate oligonucleotide production

Bachem, the Swiss pharmaceutical company, has partnered with Eli Lilly, an American pharmaceutical firm, to further advance the development of olig...

The role of technology in the medical industry

Dr Suk Kinch, Principal Design and Development Engineer at UK-based global engineering technologies company, Renishaw, has been working with its ne...

What can Manufacturing Chemist do for you?

Subscribe to Manufacturing Chemist magazine for updates on the pharmaceutical industry

Why outsourcing makes sense for orphan and rare diseases

There are as many as 8000 rare diseases, affecting 400 million people worldwide, for which there are no effective drugs available.<sup>1</sup> With...